Styczkiewicz K, Plata P, Polityńska K. Should age disqualify from life-prolonging therapy? Successful adjuvant immunotherapy in an 88-year-old octogenarian with melanoma and high cardiovascular risk. . OncoReview [Internet]. 2026Jul.9 [cited 2026Jul.21];00. Available from: https://www.journalsmededu.pl/index.php/OncoReview/article/view/3464